Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gentel Biosciences, a developer of multiplexed protein assays, has appointed Randall Durnell as its new executive vice president and COO and Dan Clutter as vice president of commercial development.
Subscribe to our email newsletter
Dr Durnell has been with Gentel for over a year where he served as the vice president of commercial operations. In his new role, Dr Durnell will be responsible for all aspects of Gentel’s commercial business, including manufacturing and corporate development.
Dr Clutter will report to Dr Durnell and has responsibility for sales, marketing and product commercialization. Prior to joining Gentel, Dr Clutter has been in sales, marketing and business development for PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand and NimbleGen.
Dr Durnell said: “Dan brings Gentel a wealth of scientific knowledge and expertise in product commercialization that directly relates to the pending launch of several new biomarker products and a low cost multiplex scanner. We are very pleased to have Dan as a member of our executive team at Gentel.”